HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.

Abstract
Previous studies have shown that Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) is uniquely able to up-regulate the expression of the peptide transporters (referred to as TAP-1 and TAP-2) and major histocompatibility complex (MHC) class I in Burkitt's lymphoma (BL) cell lines. This up-regulation is often accompanied by a restoration of antigen-presenting function as measured by the ability of these cells to present endogenously expressed viral antigen to cytotoxic T lymphocytes. Here we show that the expression of LMP1 resulted in up-regulation and nuclear translocation of RelB that were coincident with increased expression of MHC class I in BL cells. Deletion of the C-terminal activator regions (CTARs) of LMP1 significantly impaired the abilities of LMP1 to translocate RelB into the nucleus and to up-regulate the expression of antigen-processing genes. Further analysis with single-point mutations within the CTARs confirmed that the residues critical for NF-kappa B activation directly contribute to antigen-processing function regulation in BL cells. This LMP1-mediated effect was blocked following expression of either dominant negative I kappa B alpha S32/36A, an NF-kappa B inhibitor, or antisense RelB. These observations indicate that upregulation of antigen-presenting function in B cells mediated by LMP1 is signaled through the NF-kappa B subunit RelB. The data provide a mechanism by which LMP1 modulates immunogenicity of Epstein-Barr virus-infected normal and malignant cells.
AuthorsSaparna Pai, Brendan J O'Sullivan, Leanne Cooper, Ranjeny Thomas, Rajiv Khanna
JournalJournal of virology (J Virol) Vol. 76 Issue 4 Pg. 1914-21 (Feb 2002) ISSN: 0022-538X [Print] United States
PMID11799186 (Publication Type: Journal Article)
Chemical References
  • EBV-associated membrane antigen, Epstein-Barr virus
  • NF-kappa B
  • Proto-Oncogene Proteins
  • RELB protein, human
  • Transcription Factors
  • Viral Matrix Proteins
  • Transcription Factor RelB
Topics
  • Active Transport, Cell Nucleus
  • Antigen Presentation (genetics, physiology)
  • B-Lymphocytes (immunology, virology)
  • Burkitt Lymphoma (virology)
  • Cell Line, Transformed
  • Cell Nucleus (metabolism)
  • Epstein-Barr Virus Infections (virology)
  • Gene Expression Regulation, Viral
  • Herpesvirus 4, Human (genetics, physiology)
  • Humans
  • NF-kappa B (genetics, metabolism)
  • Proto-Oncogene Proteins (genetics, metabolism)
  • Transcription Factor RelB
  • Transcription Factors (genetics, metabolism)
  • Tumor Cells, Cultured
  • Viral Matrix Proteins (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: